Seventh Sense Biosystems

Seventh Sense Biosystems is improving the quality, convenience and cost-effectiveness of medical care through painless, simplified and safe blood collection. The company's proprietary Touch Activated Phlebotomy?(TAP) technology platform is being developed to eliminate the discomfort, inconvenience, and expert intervention associated with traditional blood sampling. Drawn through a painless, one-step process by almost anyone, anywhere, anytime, blood samples collected with TAP can be utilized across a broad spectrum of diagnostic applications. TAP's universal, scalable design holds the potential to not only expand the reach and effectiveness of blood collection to hard-to-sample populations and difficult settings, but also to improve the safety and ease of collection for all patients, thereby enhancing care and enabling better diagnostics.